Randomized phase II study of weekly paclitaxel versus paclitaxel and carboplatin as second-line therapy in disseminated melanoma: a multicentre trial of the Dermatologic Co-operative Oncology Group (DeCOG). - Zimpfer-Rechner,C.; Hofmann,U.; Figl,R.; Becker,J.C.; Trefzer,U.; Keller,I.; Hauschild,A.; Schadendorf,D. (Melanoma Res, 2003)